01Aug 2021
A Decade of Jakinibs: what have we learned and what may be the future

A Decade of Jakinibs: what have we learned and what may be the future

The discovery of cytokines and their role in immune and inflammatory disease led to the development a plethora of targeted biologic therapies. Later, efforts to understand mechanisms of cytokine signal transduction led to the discovery of Janus kinases (JAKs), which themselves were quickly identified as therapeutic targets. It has been a decade since the first JAK inhibitors (jakinibs) were approved and now there are nine jakinibs approved for treatment of rheumatologic, dermatologic, hematologic, and gastrointestinal indications along with emergency authorization for Covid‐19...

  • #family health

Like

Save

Share